肿瘤大小辅助甲状腺髓样癌术前颈部淋巴结转移风险评估的回顾性研究:基于SEER数据库OA
Tumor size as a predictor for preoperative assessment of cervical lymph node metastasis in medullary thyroid car-cinoma:a retrospective study based on the SEER database
目的:基于SEER数据库,系统评估甲状腺髓样癌(MTC)颈部淋巴结转移的影响因素,重点探讨肿瘤大小与淋巴结转移的剂量-反应关系及其最佳临床切割值.方法:提取监测、流行病学和最终结果(SEER)数据库2000-2023年确诊的MTC病人2 875例.采用单因素及多因素logistic回归分析淋巴结转移的独立影响因素,以泊松回归估算风险比(RR);使用限制性立方样条(RCS)评估剂量-反应关系;通过最大化秩统计量(MAXSTAT)确定最佳切割值,并采用内部验证、校准曲线和决策曲线分析(DCA)评估模型性能,同时按淋巴结清扫范围进行敏感性分析.结果:多因素logistic回归和敏感性分析显示,女性(OR=0.40,P<0.001)及年龄≥75岁(OR=0.40,P<0.001)为保护因素,肿瘤大小是重要的独立风险因素(趋势P<0.001).RCS显示肿瘤大小与淋巴结转移风险呈近似对数线性关系(整体P<0.001).最佳切割值为直径12 mm,以该值分组后,>12 mm组淋巴结转移率显著高于≤12 mm组(52.6%比20.2%,OR=4.38,P<0.001).内部验证显示该阈值预测淋巴结转移的受试者工作特征曲线下面积(AUC)为0.657(95%CI:0.629~0.686),校准曲线及DCA提示模型具有临床净获益.敏感性分析证实肿瘤大小效应在不同清扫范围亚组中均稳健.结论:肿瘤大小是MTC淋巴结转移的重要独立预测因子,12 mm可作为术前辅助风险分层的候选阈值,提示临床应加强影像学评估.该阈值需与降钙素、RET基因突变及临床N分期等联合解读,为制定治疗方案提供参考.由于SEER数据库缺乏上述分子及生化信息,该阈值尚不能独立作为淋巴结清扫范围的决策依据.
Objective To systematically evaluate influencing factors of cervical lymph node metastasis in medullary thyroid carcinoma(MTC)patients using the SEER database,with a focus on the dose-response relationship between tumor size and lymph node metastasis,and to determine the optimal clinical cut-off value.Methods A total of 2,875 MTC patients diagnosed between 2000 and 2023 were extracted from the Surveillance,Epidemiology,and End Results(SEER)database.Univariate and multivariate logistic regression were used to identify independent predictors,with Poisson regression estimating risk ratios(RR).Restricted cubic spline(RCS)assessed the dose-response relationship,and maximally selected rank statistics(MAXSTAT)determined the optimal cut-off value.Model performance was assessed through internal validation,calibration curves,and decision curve analysis(DCA),and sensitivity analyses were conducted stratified by the extent of lymph node dissection.Results Multivariate logistic regression and sensitivity analyses showed that female sex(OR=0.40,P<0.001)and age≥75 years(OR=0.40,P<0.001)were protective factors,while tumor size was a significant independent risk factor(P<0.001).RCS revealed an approximate log-linear relationship between tumor size and lymph node metastasis risk(overall P<0.001).The optimal cut-off was diameter 12 mm;using this threshold,>12 mm group had a significantly higher metastasis rate than the≤12 mm group(52.6%vs.20.2%,OR=4.38,P<0.001).Internal validation yielded an area under the receiver operating characteristic curve(AUC)of 0.657(95%CI:0.629-0.686),with calibration curves and DCA indicating clinical net benefit.Sensitivity analyses confirmed the robustness of the tumor size effect across different dissection extent subgroups.Conclusions Tumor size is an important independent predictor of lymph node metastasis in MTC.The 12 mm threshold may serve as a candidate ancillary tool for preoperative risk stratification,prompting enhanced imaging evaluation.This threshold should be interpreted in conjunction with calcitonin levels,RET mutation status,and clinical N stage to inform treatment planning.Given the absence of these molecular and biochemical data in the SEER database,this threshold alone cannot be used as an independent criterion for determining the extent of lymph node dissection.
田元;刘勋
中国医科大学附属盛京医院普通外科,辽宁 沈阳 110004中国医科大学附属盛京医院普通外科,辽宁 沈阳 110004
医药卫生
甲状腺髓样癌颈部淋巴结转移肿瘤大小监测、流行病学和最终结果(SEER)数据库
Medullary thyroid carcinomaCervical lymph node metastasisTumor sizeSurveillance,Epidemiology,and End Results(SEER)database
《外科理论与实践》 2026 (4)
306-318,13
辽宁省科技计划联合计划(自然科学基金)(2024-MSLH-583)
评论